Wilson Sonsini Goodrich & Rosati advised Totient on the deal.AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
